1. JHU, Cumulative confirmed COVID-19 deaths. 2021.
2. Kidman, R., et al., Estimates and Projections of COVID-19 and Parental Death in the US. JAMA pediatrics, 2021.
3. Fugazza, M., Impact of the COVID-19 Pandemic on Commodities Exports to China: UNCTAD Research Paper No. 44. 2020.
4. Fairlie, R., The impact of COVID‐19 on small business owners: Evidence from the first three months after widespread social‐distancing restrictions. Journal of economics & management strategy, 2020. 29(4): p. 727-740.
5. Jordan, H.T., et al., Persistent mental and physical health impact of exposure to the September 11, 2001 World Trade Center terrorist attacks. Environmental health, 2019. 18(1): p. 1-16.
6. UNICEF, Covid-19 Vaccine Market Dashboard. 2021.
7. Palacios, R., et al., Efficacy and safety of a COVID-19 inactivated vaccine in healthcare professionals in Brazil: the PROFISCOV study. 2021.
8. Chagla, Z., The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19≥ 7 days after the 2nd dose. Annals of Internal Medicine, 2021. 174(2): p. JC15.
9. Abu-Raddad, L.J., H. Chemaitelly, and A.A. Butt, Effectiveness of the BNT162b2 Covid-19 Vaccine against the B. 1.1. 7 and B. 1.351 Variants. New England Journal of Medicine, 2021.
10. Mesa, D.O., et al., Quantifying the impact of vaccine hesitancy in prolonging the need for Non-Pharmaceutical Interventions to control the COVID-19 pandemic. 2021.
11. Dinga, J.N., L.K. Sinda, and V.P. Titanji, Assessment of vaccine hesitancy to a COVID-19 vaccine in Cameroonian adults and its global implication. Vaccines, 2021. 9(2): p. 175.
12. Cooper, S., et al., Vaccine hesitancy–a potential threat to the achievements of vaccination programmes in Africa. Human vaccines & immunotherapeutics, 2018. 14(10): p. 2355-2357.
13. Hickler, B., S. Guirguis, and R. Obregon, Vaccine special issue on vaccine hesitancy. Vaccine, 2015. 34(33): p. 4155-4156.
14. Goodman, J. and F. Carmichael, Coronavirus: Bill Gates ‘microchip’conspiracy theory and other vaccine claims fact-checked. BBC Reality Check. May, 2020.
15. Ovenseri-Ogbomo, G.O., et al., Factors associated with the myth about 5G network during COVID-19 pandemic in sub-Saharan Africa. Journal of Global Health Reports, 2020.
16. Bertoncello, C., et al., Socioeconomic determinants in vaccine hesitancy and vaccine refusal in Italy. Vaccines, 2020. 8(2): p. 276.
17. Nguyen, L.H., et al., Racial and ethnic differences in COVID-19 vaccine hesitancy and uptake. medRxiv, 2021.
18. Wagner, A.L., et al., Comparisons of vaccine hesitancy across five low-and middle-income countries. Vaccines, 2019. 7(4): p. 155.
19. Green, M.S., et al., A study of ethnic, gender and educational differences in attitudes toward COVID-19 vaccines in Israel–implications for vaccination implementation policies. Israel Journal of Health Policy Research, 2021. 10(1): p. 1-12.
20. Murphy, J., et al., Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nature communications, 2021. 12(1): p. 1-15.
21. Lucia, V.C., A. Kelekar, and N.M. Afonso, COVID-19 vaccine hesitancy among medical students. Journal of Public Health (Oxford, England), 2020.
22. Killgore, W.D., et al., The COVID-19 Vaccine Is Here—Now Who Is Willing to Get It? Vaccines, 2021. 9(4): p. 339.
23. Lockyer, B., et al., Understanding COVID‐19 misinformation and vaccine hesitancy in context: Findings from a qualitative study involving citizens in Bradford, UK. Health Expectations, 2021.
24. Oguntibeju, O.O., Medicinal plants with anti-inflammatory activities from selected countries and regions of Africa. Journal of inflammation research, 2018. 11: p. 307.
25. Sharifi-Rad, J., et al., Medicinal plants used in the treatment of tuberculosis-Ethnobotanical and ethnopharmacological approaches. Biotechnology advances, 2020: p. 107629.
26. Wong, L., P. Wong, and S. AbuBakar, Vaccine hesitancy and the resurgence of vaccine preventable diseases: the way forward for Malaysia, a Southeast Asian country. Human vaccines & immunotherapeutics, 2020. 16(7): p. 1511-1520.
27. PRC. Religiosity. 2008 [cited 2021 Oct 19]; Available from: https://www.pewresearch.org/global/2008/09/17/chapter-2-religiosity/.
28. Schwarzinger, M., et al., COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics. The Lancet Public Health, 2021. 6(4): p. e210-e221.
29. Harapan, H., et al., Acceptance of a COVID-19 vaccine in Southeast Asia: a cross-sectional study in Indonesia. Frontiers in public health, 2020. 8.
30. Noffke, J.L. and S.H. McFadden, Denominational and age comparisons of God concepts. Journal for the Scientific Study of Religion, 2001. 40(4): p. 747-756.
31. Mesele, M., COVID-19 Vaccination Acceptance and Its Associated Factors in Sodo Town, Wolaita Zone, Southern Ethiopia: Cross-Sectional Study. Infection and Drug Resistance, 2021. 14: p. 2361.
32. Dereje, N., et al., COVID-19 Vaccine hesitancy in Addis Ababa, Ethiopia: A mixed-methods study. medRxiv, 2021.
33. Handebo, S., et al., Determinant of intention to receive COVID-19 vaccine among school teachers in Gondar City, Northwest Ethiopia. Plos one, 2021. 16(6): p. e0253499.
34. Elhadi, Y.A.M., et al., Intention of Healthcare Workers to Receive COVID-19 Vaccine: A Cross-Sectional Survey in 10 Countries in Eastern Mediterranean Region. medRxiv, 2021.
35. Alwi, S.S., et al., A survey on COVID-19 vaccine acceptance and concern among Malaysians. BMC public health, 2021. 21(1): p. 1-12.
36. Reiter, P.L., M.L. Pennell, and M.L. Katz, Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? Vaccine, 2020. 38(42): p. 6500-6507.
37. Wagner, A.L., et al., Demographics of Vaccine Hesitancy in Chandigarh, India. Frontiers in medicine, 2021. 7: p. 1062.
38. Puri, N., et al., Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases. Human vaccines & immunotherapeutics, 2020. 16(11): p. 2586-2593.
39. Carrieri, V., L. Madio, and F. Principe, Vaccine hesitancy and (fake) news: Quasi‐experimental evidence from Italy. Health economics, 2019. 28(11): p. 1377-1382.
40. Chadwick, A., et al., Online social endorsement and Covid-19 vaccine hesitancy in the United Kingdom. Social Media+ Society, 2021. 7(2): p. 20563051211008817.
41. Hong, H. and H.J. Kim, Antecedents and Consequences of Information Overload in the COVID-19 Pandemic. International Journal of Environmental Research and Public Health, 2020. 17(24): p. 9305.
42. Soares, P., et al., Factors associated with COVID-19 vaccine hesitancy. Vaccines, 2021. 9(3): p. 300.
43. Sallam, M., et al., High rates of COVID-19 vaccine hesitancy and its association with conspiracy beliefs: A study in Jordan and Kuwait among other Arab countries. Vaccines, 2021. 9(1): p. 42.
44. Ali, M. and A. Hossain, What is the extent of COVID-19 vaccine hesitancy in Bangladesh?: A cross-sectional rapid national survey. medRxiv, 2021.
45. Shih, S.-F., et al., Vaccine Hesitancy and Rejection of a Vaccine for the Novel Coronavirus in the United States. Frontiers in Immunology, 2021. 12: p. 2275.
46. Østergaard, S.D., et al., Thromboembolism and the Oxford–AstraZeneca COVID-19 vaccine: side-effect or coincidence? The Lancet, 2021. 397(10283): p. 1441-1443.
47. Bergwerk, M., et al., COVID-19 breakthrough infections in vaccinated health care workers. New England Journal of Medicine, 2021.
48. Orisakwe, O.E., C.N. Orish, and E.O. Nwanaforo, Coronavirus disease (COVID-19) and Africa: acclaimed home remedies. Scientific African, 2020: p. e00620.
49. Barello, S., et al., ‘Vaccine hesitancy’among university students in Italy during the COVID-19 pandemic. European journal of epidemiology, 2020. 35(8): p. 781-783.
50. Riad, A., et al., Prevalence and Drivers of COVID-19 Vaccine Hesitancy among Czech University Students: National Cross-Sectional Study. Vaccines, 2021. 9(9): p. 948.
51. Al-Mulla, R., et al., COVID-19 Vaccine Hesitancy in a Representative Education Sector Population in Qatar. Vaccines, 2021. 9(6): p. 665.
52. Vapiwala, N., et al., Patient initiation of complementary and alternative medical therapies (CAM) following cancer diagnosis. The Cancer Journal, 2006. 12(6): p. 467-474.